Skip to main content
TipRanks
Go Ultimate75% OFF

Recursion Pharmaceuticals (RXRX) Income Statement

4,728 Followers

Recursion Pharmaceuticals Income Statement

Last quarter (Q3 2026), Recursion Pharmaceuticals's total revenue was $18.55M, an increase of 258.49% from the same quarter last year. In Q3, Recursion Pharmaceuticals's net income was $-119.04M. See Recursion Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
$ 74.68M$ 58.84M$ 43.88M$ 39.68M$ 10.00M
$ -46.27M$ 13.60M$ 1.29M$ -8.59M$ 10.00M
$ 601.86M$ 492.61M$ 351.35M$ 237.13M$ 192.78M
Depreciation and Amortization$ 83.70M$ 36.49M$ 24.40M$ 11.76M$ 8.40M
$ -559.38M$ -426.72M$ -307.63M$ -227.66M$ -175.12M
$ -648.13M$ -479.00M$ -350.06M$ -245.73M$ -182.78M
$ 3.24M$ 14.22M$ 17.93M$ 6.25M$ -3.70M
$ -644.89M$ -464.79M$ -332.13M$ -239.48M$ -186.48M
$ -644.76M$ -463.66M$ -328.07M$ -239.48M$ -186.48M
Per Share Metrics
Basic EPS$ -1.44$ -1.69$ -1.58$ -1.36$ -1.05
Diluted EPS$ -1.44$ -1.69$ -1.58$ -1.36$ -1.05
Weighted Average Shares Outstanding447.45M274.21M207.85M175.54M170.27M
Weighted Average Shares Outstanding (Diluted)447.45M274.21M207.85M175.54M170.27M

Currency in USD

Recursion Pharmaceuticals Earnings and Revenue History

-800M-400M0400M-4500 %-3000 %-1500 %0 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin